Product Data Sheet

AZD4625

Catalog No. A24541

main product photo
AZD4625 (Compound 21) is a highly potent, selective, covalent, and allosteric inhibitor of the mutant GTPase KRAS^G12C. It exhibits strong target engagement and high oral bioavailability, making it a promising candidate for the treatment of KRAS^G12C-driven cancers.
Chemical Information
Catalog NumA24541
M. Wt486.90
FormulaC24H21ClF2N4O3
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.nan
Synonyms
SMILESC=CC(N1C[C@H]2N(C3=C4C(OCC2)=C(Cl)[C@@]([C@@]5=C(F)C=CC=C5O)=C(F)C4=NC=N3)C[C@H]1C)=O
Biological Activity
DescriptionAZD4625 (Compound 21) is a highly potent, selective, covalent, and allosteric inhibitor of the mutant GTPase KRAS^G12C. It exhibits strong target engagement and high oral bioavailability, making it a promising candidate for the treatment of KRAS^G12C-driven cancers.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.